Methodist maternal-fetal specialist weighs in on claims linking Tylenol use in pregnancy to autism

On Monday, President Donald Trump said the FDA will inform healthcare providers that using Tylenol and its generic form acetaminophen during pregnancy can be associated with what he described as an increased risk of autism. The FDA has also begun the process of changing the drug label to include a warning.

Dr. Emily Patel, a maternal-fetal medicine specialist with Methodist Hospital in Omaha, emphasized the importance of understanding the source and nature of these claims.

"First off, I think it's really important to note that this is coming from a politician, not from the medical community, and that overwhelmingly, the medical community still stands behind the use of Tylenol in pregnancy," Patel said.

Patel explained the critical distinction between correlation and causation, noting that no causal relationship has been established.

KMTV: Omaha doctor weighs in on Trump administration's claims linking Tylenol use in pregnancy to autism